Using Ru-PdO@MXenes-Nanostructured Electrochemical Immunosensing System for Selective Detection of Multiple Breast Biomarkers (HER2 and MUC1)
ACS Applied Bio Materials · 21.07.2025 · 8 (7) · 5743-5756
DOI: 10.1021/acsabm.5c00452 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 09.06.2025. Verfasst von Amany M Sawy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biosensors Research Centre, Zewail City of Science and Technology, Sixth October City, Giza, Cairo 12578, Egypt. Hauptthemen laut MEDLINE: Mucin-1, Erb-b2 Receptor Tyrosine Kinases, Biomarkers, Tumor, Electrochemical Techniques. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Science and Technology Development Fund.
Abstract (Originalsprache)
Early diagnosis of breast cancer relies on detecting multiple cancer biomarkers, which significantly enhances diagnostic accuracy. In this study, we developed a novel electrochemical dual immunosensor for the simultaneous detection of human epidermal growth factor receptor 2 (HER2) and mucin 1 (MUC1) biomarkers. The sensor is based on Ti3C2Tx MXene loaded with ruthenium (Ru)/palladium oxide (PdO) nanostructures Ru/PdO@MXene and poly(aniline-co-pyrrole) copolymer substrate. The Ru/PdO@MXene enhanced stability, sensitivity, and impedimetric performance, while the copolymer improved antibody immobilization. Optimized experimental parameters enabled enhanced sensor sensitivity and selectivity. Electrochemical impedance spectroscopy (EIS) revealed excellent linearity across 1.0 fg mL-1 to 100 ng mL-1 for HER2 and 1.0 fg mL-1 to 200 ng mL-1 for MUC1. The sensor's detection limits reached 0.26 fg mL-1 (HER2) and 0.28 fg mL-1 (MUC1), with outstanding sensitivity of 34.45 and 13.86 ng·mL-1, respectively. In addition, the sensor demonstrated high selectivity, stability, repeatability, and a detection time of 20 min. Spiked serum sample testing yielded recovery rates of 89.6-102.7% (HER2) and 85.69-105.8% (MUC1). This platform shows great promise for early breast cancer diagnosis and could be extended to other clinically relevant biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biosensors Research Centre, Zewail City of Science and Technology, Sixth October City, Giza, Cairo 12578, Egypt.
- Spectroscopy Department, Physics Research Institute, National Research Centre, Giza, Cairo 12622, Egypt.
- Department of Gynecology and Obstetrics, Affiliated Hospital of Yangzhou University, 225009 Yangzhou, China.
ORCID-Profile: Rabeay Y A Hassan
Förderung
- Science and Technology Development Fund
Zitieren
APA
Sawy, A. M., Anis, B., Cui, S., & Hassan, R. Y. A. (2025). Using Ru-PdO@MXenes-Nanostructured Electrochemical Immunosensing System for Selective Detection of Multiple Breast Biomarkers (HER2 and MUC1). ACS Applied Bio Materials, 8(7), 5743-5756. https://doi.org/10.1021/acsabm.5c00452
Vancouver
Sawy AM, Anis B, Cui S, Hassan RYA. Using Ru-PdO@MXenes-Nanostructured Electrochemical Immunosensing System for Selective Detection of Multiple Breast Biomarkers (HER2 and MUC1). ACS Applied Bio Materials. 2025;8(7):5743-5756. doi:10.1021/acsabm.5c00452
BibTeX
@article{Sawy2025,
author = {Sawy, Amany M and Anis, Badawi and Cui, Shuna and Hassan, Rabeay Y A},
title = {Using Ru-PdO@MXenes-Nanostructured Electrochemical Immunosensing System for Selective Detection of Multiple Breast Biomarkers (HER2 and MUC1)},
journal = {ACS Applied Bio Materials},
year = {2025},
volume = {8},
number = {7},
pages = {5743--5756},
doi = {10.1021/acsabm.5c00452}
}
EUVIMED